Please wait while the formulary information is being retrieved.
NYSTATIN (NYSTATIN)
- Cutaneous candidiasis
100,000 unit/gram topical ointment
- Apply to the affected area(s) by topical route 2 times per day
100,000 unit/gram topical cream
- Apply to the affected area(s) by topical route 2 times per day
Cutaneous candidiasis
- Apply to the affected area(s) by topical route 2 times per day
- Apply to the affected area(s) by topical route 3 times per day
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- No disease contraindications
NYSTATIN (NYSTATIN)
- Cutaneous candidiasis
- None
- None
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- Eczema
- Pruritus of skin
- Skin irritation
- Skin rash
- Treatment site sequelae
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Nystatin (topical Cream, Oint)
- Severity Level:
C
- Additional Notes: Drug poorly absorbed from intact skin.
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
Nystatin (top, Vag)
Oral drug may be used in neonates.
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Unknown | Not known; no or inclusive data | Oral drug may be used in neonates. |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Cutaneous candidiasis | |
| B37.2 | Candidiasis of skin and nail |
| 0-9 | A-Z |
|---|---|
| B37.2 | Candidiasis of skin and nail |
Formulary Reference Tool